National Cancer Institute; Call for Nominations for the National Cancer Institute Director's Consumer Liaison Group, 14476-14477 [E8-5213]
Download as PDF
<![CDATA[
14476
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices
Name of Committee: Oncological Sciences
Integrated Review Group Clinical Oncology
Study Section.
Date: May 19–20, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sharon K. Gubanich, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892, (301) 435–
1767, gubanics@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group Macromolecular Structure and
Function E Study Section.
Date: May 27–28, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: La Jolla Shores Hotel, 8110 Camino
del Oro, La Jolla, CA 92037.
Contact Person: Nitsa Rosenzweig, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7760, Bethesda, MD 20892, (301) 435–
1747, rosenzweign@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5206 Filed 3–17–08; 8:45 am]
National Cancer Institute; Call for
Nominations for the National Cancer
Institute Director’s Consumer Liaison
Group
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Institutes of Health Peer
Review Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institutes of
Health Peer Review Advisory Committee.
Date: April 30, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: Provide technical and scientific
advice to the Director, National Institutes of
Jkt 214001
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:39 Mar 17, 2008
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5212 Filed 3–17–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
VerDate Aug<31>2005
Health (NIH), the Deputy Director for
Extramural Research, NIH and the Director,
Center for Scientific Review (CSR), on
matters relating broadly to review procedures
and policies for the evaluation of scientific
and technical merit of applications for grants
and awards.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Ballroom Level, Bethesda, MD
20814.
Contact Person: Cheryl A. Kitt, PhD, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3030,
MSC 7776, Bethesda, MD 20892, 301–435–
1112, kittc@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
The National Cancer Institute (NCI),
the Federal Government’s primary
agency for cancer research, is seeking
nominations for up to six (6) new
members of the NCI Director’s
Consumer Liaison Group (DCLG) who
will be appointed in July 2008. The
DCLG is a Federal chartered advisory
committee of the NCI. It consists of 16
consumer advocates who are involved
in cancer advocacy and who reflect the
diversity among those whose lives are
affected by cancer.
The mission of the DCLG is to advise,
assist, consult with, and make
recommendations to the NCI Director,
from the perspective and viewpoint of
cancer consumer advocates on a wide
variety of issues, programs, and research
priorities. The DCLG serves as a channel
for consumer advocates to voice their
views and concerns. Specifically, the
DCLG members:
• Help develop and establish
processes, mechanisms, and criteria for
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
identifying appropriate consumer
advocates to serve on a variety of
program and policy advisory
committees responsible for advancing
the mission of the NCI.
• Serve as a primary forum for
discussing issues and concerns and
exchanging viewpoints that are
important to the broad development of
the NCI programmatic and research
priorities.
• Establish and maintain strong
collaborations between the NCI and the
cancer advocacy community to reach
common goals.
Eligibility Requirements for Individual
Members: To serve on the DCLG, a
member must meet the following
minimum eligibility requirements:
• Be involved in the cancer
experience as a cancer survivor, a caregiver to someone who has cancer, or a
professional or volunteer who works
with survivors or those affected by
cancer; and
• Represent a constituency with
whom you communicate regularly on
cancer issues and be able to serve as a
conduit for information both to and
from your constituency.
DCLG members must be committed to
participate fully in all activities of the
DCLG, including at least two meetings
per year in the Bethesda, MD area,
conference calls, and working group
activities.
Criteria for Evaluating Individual
Candidates: Nominees who meet the
minimum eligibility requirements will
be further assessed based on the
following criteria:
• Cancer advocacy experience;
• Possession of strong leadership
skills;
• Communication and collaboration
skills;
• Ability to represent/advise on
broad, cross-cutting cancer issues,
including those NCI priorities identified
by the NCI Director;
• Ability to facilitate dialogue
between NCI and the cancer advocacy
community.
Characteristics of the DCLG: In
addition to the criteria for individual
candidates, the following characteristics
of the DCLG as a group are intended to
ensure that it reflects the breadth and
diversity of the consumer advocacy
community:
• Ethnic and cultural diversity;
• A broad mix of cancer sites;
• Representation of the medically
underserved;
• A range of cancer advocacy
organizations (from small, local to
regional and national);
• A diversity of ages and gender;
• Geographic diversity (including
urban/rural areas).
E:\FR\FM\18MRN1.SGM
18MRN1
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices
Selection Process: A call for
nominations is disseminated annually
to a broad range of local, regional, and
national organizations to encourage the
nomination of candidates reflecting the
diversity sought for the DCLG. All
nominees are screened for eligibility
and then according to criteria for
evaluating individual candidates. A list
of highly qualified candidates who
reflect balance and diversity of
representation is forwarded to the NCI
Director, who selects the DCLG
members.
NCI encourages nomination of
candidates reflecting the diversity of the
cancer advocacy community.
Nominations can be made by
organizations, including local/regional
and national groups, or individuals,
including self-nominations. In order to
be considered for the DCLG, send a
resume or curriculum vitae, two
references and a cover letter detailing
your interest in participating in the
DCLG. Please be sure to include your
advocacy or voluntary organization
affiliation, address, phone number, and
email address. Send the information to:
DCLG 2008 Member Nomination, c/o
Ms. Barbara Guest, Executive Secretary,
Office of Advocacy Relations, National
Cancer Institute, 31 Center Drive,
Building 31, Room 10A28, Bethesda,
MD 20892–2580, guestb@mail.nih.gov,
Phone Number: 301–496–0307, Fax:
301–480–7558.
Nominations must be postmarked by
April 15, 2008.
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5213 Filed 3–17–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5191–N–05]
Notice of Proposed Information
Collection: Comment Request;
Disposition of HUD-Owned Single
Family Assets in Asset Control Areas
Office of the Assistant
Secretary for Housing, HUD.
ACTION: Notice.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: The proposed information
collection requirement described below
will be submitted to the Office of
Management and Budget (OMB) for
review, as required by the Paperwork
Reduction Act. The Department is
soliciting public comments on the
subject proposal.
VerDate Aug<31>2005
17:39 Mar 17, 2008
Jkt 214001
May 19, 2008.
Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
Control Number and should be sent to:
Lillian Deitzer, Departmental Reports
Management Officer, QDAM,
Department of Housing and Urban
Development, 451 7th Street, SW.,
Washington, DC 20410; e-mail
Lillian_L._Deitzer@HUD.gov or
telephone (202) 402–8048.
FOR FURTHER INFORMATION CONTACT:
Vance T. Morris, Director, Office of
Single Family Program Development,
Department of Housing and Urban
Development, 451 7th Street SW.,
Washington, DC 20410, telephone (202)
708–2121 (this is not a toll free number)
for copies of the proposed forms and
other available information.
SUPPLEMENTARY INFORMATION: The
Department is submitting the proposed
information collection to OMB for
review, as required by the Paperwork
Reduction Act of 1995 (44 U.S.C.
Chapter 35, as amended).
This Notice is soliciting comments
from members of the public and affected
agencies concerning the proposed
collection of information to: (1) Evaluate
whether the proposed collection is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (3) Enhance the quality,
utility, and clarity of the information to
be collected; and (4) Minimize the
burden of the collection of information
on those who are to respond; including
the use of appropriate automated
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses.
This Notice also lists the following
information:
Title of Proposal: Single Family
Housing—Disposition of HUD-Owned
Single Family Assets in Asset Control
Areas.
OMB Control Number, if applicable:
2502–NEW.
Description of the need for the
information and proposed use:
The proposed rule would promulgate
regulations for HUD’s ‘‘Asset Control
Areas’’ (ACA) program. The ACA
program permits the sale of HUD-held
single-family homes and mortgage assets
available for sale at a discount to units
of general local government, states,
Indian tribes, nonprofit organizations
and for-profit entities to provide
DATES:
ADDRESSES:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
14477
homeownership opportunities and to
promote neighborhood revitalization.
The information requested is required
for the administration and oversight of
the ACA program. Specifically, HUD
will be able to ascertain whether ACA
participants are adhering to eligible
purchaser, rehabilitation, resale price,
etc. requirements imposed by HUD as a
condition of receiving ACA properties at
a discount.
Agency form numbers, if applicable:
None.
Estimation of the total numbers of
hours needed to prepare the information
collection including number of
respondents, frequency of response, and
hours of response: The number of
burden hours is 2,091. The number of
respondents is 18, the total number of
annual responses is 360, the frequency
of response is on occasion, and the
average burden hour per response is 6.
Status of the proposed information
collection: This is a new collection.
Authority: The Paperwork Reduction Act
of 1995, 44 U.S.C., Chapter 35, as amended.
Dated: March 12, 2008.
Frank L. Davis,
General Deputy Assistant Secretary for
Housing-Deputy Federal Housing
Commissioner.
[FR Doc. E8–5366 Filed 3–17–08; 8:45 am]
BILLING CODE 4210–67–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5187–N–12]
Alternative Housing Pilot Program
Evaluation Baseline Survey
Office of the Chief Information
Officer, HUD
ACTION: Notice.
AGENCY:
SUMMARY: The proposed information
collection requirement described below
has been submitted to the Office of
Management and Budget (OMB) for
review, as required by the Paperwork
Reduction Act. The Department is
soliciting public comments on the
subject proposal.
HUD is conducting an evaluation of
FEMA’s Alternative Housing Pilot
Program (AHPP). Due to the immediate
need to improve the temporary housing
situation for many victims of Hurricanes
Katrina and Rita, FEMA is rapidly
developing the alternative housing. In
order to measure program effectiveness,
the evaluation requires that we do a
baseline evaluation of households
before they receive a housing unit.
Because it has taken longer than
expected for FEMA’s AHPP to be
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Notices]
[Pages 14476-14477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5213]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Call for Nominations for the National
Cancer Institute Director's Consumer Liaison Group
The National Cancer Institute (NCI), the Federal Government's
primary agency for cancer research, is seeking nominations for up to
six (6) new members of the NCI Director's Consumer Liaison Group (DCLG)
who will be appointed in July 2008. The DCLG is a Federal chartered
advisory committee of the NCI. It consists of 16 consumer advocates who
are involved in cancer advocacy and who reflect the diversity among
those whose lives are affected by cancer.
The mission of the DCLG is to advise, assist, consult with, and
make recommendations to the NCI Director, from the perspective and
viewpoint of cancer consumer advocates on a wide variety of issues,
programs, and research priorities. The DCLG serves as a channel for
consumer advocates to voice their views and concerns. Specifically, the
DCLG members:
Help develop and establish processes, mechanisms, and
criteria for identifying appropriate consumer advocates to serve on a
variety of program and policy advisory committees responsible for
advancing the mission of the NCI.
Serve as a primary forum for discussing issues and
concerns and exchanging viewpoints that are important to the broad
development of the NCI programmatic and research priorities.
Establish and maintain strong collaborations between the
NCI and the cancer advocacy community to reach common goals.
Eligibility Requirements for Individual Members: To serve on the
DCLG, a member must meet the following minimum eligibility
requirements:
Be involved in the cancer experience as a cancer survivor,
a care-giver to someone who has cancer, or a professional or volunteer
who works with survivors or those affected by cancer; and
Represent a constituency with whom you communicate
regularly on cancer issues and be able to serve as a conduit for
information both to and from your constituency.
DCLG members must be committed to participate fully in all
activities of the DCLG, including at least two meetings per year in the
Bethesda, MD area, conference calls, and working group activities.
Criteria for Evaluating Individual Candidates: Nominees who meet
the minimum eligibility requirements will be further assessed based on
the following criteria:
Cancer advocacy experience;
Possession of strong leadership skills;
Communication and collaboration skills;
Ability to represent/advise on broad, cross-cutting cancer
issues, including those NCI priorities identified by the NCI Director;
Ability to facilitate dialogue between NCI and the cancer
advocacy community.
Characteristics of the DCLG: In addition to the criteria for
individual candidates, the following characteristics of the DCLG as a
group are intended to ensure that it reflects the breadth and diversity
of the consumer advocacy community:
Ethnic and cultural diversity;
A broad mix of cancer sites;
Representation of the medically underserved;
A range of cancer advocacy organizations (from small,
local to regional and national);
A diversity of ages and gender;
Geographic diversity (including urban/rural areas).
[[Page 14477]]
Selection Process: A call for nominations is disseminated annually
to a broad range of local, regional, and national organizations to
encourage the nomination of candidates reflecting the diversity sought
for the DCLG. All nominees are screened for eligibility and then
according to criteria for evaluating individual candidates. A list of
highly qualified candidates who reflect balance and diversity of
representation is forwarded to the NCI Director, who selects the DCLG
members.
NCI encourages nomination of candidates reflecting the diversity of
the cancer advocacy community. Nominations can be made by
organizations, including local/regional and national groups, or
individuals, including self-nominations. In order to be considered for
the DCLG, send a resume or curriculum vitae, two references and a cover
letter detailing your interest in participating in the DCLG. Please be
sure to include your advocacy or voluntary organization affiliation,
address, phone number, and email address. Send the information to: DCLG
2008 Member Nomination, c/o Ms. Barbara Guest, Executive Secretary,
Office of Advocacy Relations, National Cancer Institute, 31 Center
Drive, Building 31, Room 10A28, Bethesda, MD 20892-2580,
guestb@mail.nih.gov, Phone Number: 301-496-0307, Fax: 301-480-7558.
Nominations must be postmarked by April 15, 2008.
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-5213 Filed 3-17-08; 8:45 am]
BILLING CODE 4140-01-M
